BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Factor Bioscience Files Patent Infringement Lawsuit Against Cellectis and AstraZeneca

Factor Bioscience Inc. (Factor), a Cambridge, Massachusetts-based biotechnology company focused on using its pioneering gene-editing platform to devel...

September 29, 2025 | News

Evonik and AMSilk Launch Dedicated Manufacturing Line for High-Performance Silk Proteins

Dedicated manufacturing line for AMSilk high-performance silk proteins High tech industrial biomaterials meet leading apparel brands’ demand for s...

September 26, 2025 | News

Lunit and CellCarta Form Global Partnership to Advance AI-Powered Pathology in Clinical Trials

Lunit , a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, announced a strategic partnership with CellCarta, a globa...

September 25, 2025 | News

Lonza and RION Partner to Scale Manufacturing of Exosome-Based Therapy PEP™

Lonza to support cGMP manufacturing of RION’s Purified Exosome Product™ (PEP™), a platelet-derived exosome-based drug candidate ...

September 24, 2025 | News

Merck Opens €150 Million Climate-Neutral Filter Manufacturing Facility in Cork

Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilience Merck’s firs...

September 23, 2025 | News

Merck and Siemens Forge Digital Alliance to Transform Drug Discovery and Manufacturing

Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens...

September 24, 2025 | News

Sanofi and Regeneron Receive CHMP Recommendation for Dupixent in Chronic Spontaneous Urticaria in EU

Recommendation for adults and adolescents based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo ...

September 23, 2025 | News

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Advance Treatments for Epidermolysis Bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB...

September 23, 2025 | News

OGT secures FDA De Novo classification for CytoCell® KMT2A FISH probe as companion diagnostic to Syndax’s Revuforj®

OGT, a leading global provider of genomic diagnostic and research solutions, announced that the U.S. Food and Drug Administration (FDA) has granted th...

September 23, 2025 | News

Henlius and Organon Secure EC Approvals for Denosumab Biosimilars BILDYOS® and BILPREVDA®

Shanghai Henlius Biotech, Inc., and Organon announced the European Commission (EC) has granted marketing authorization for BILDYOS® (de...

September 22, 2025 | News

Ono Pharmaceutical Wins EU Approval for Vimseltinib as First TGCT Therapy

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., a...

September 19, 2025 | News

OGT and QIAGEN Partner to Deliver End-to-End NGS Workflow With SureSeq™ Panels and QCI® Interpret

The new co-marketing and distribution partnership enables SureSeq™ NGS panel customers to purchase QIAGEN’s tertiary analysis software QIAGEN...

September 19, 2025 | News

WuXi Biologics Secures First Turkish GMP Certification for Three Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

September 18, 2025 | News

EC Approves Alteogen’s EYLUXVI® as Eylea® Biosimilar for Major Ophthalmic Indications

EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through it...

September 18, 2025 | News

Stay Connected